Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms. - Wikidata - awgldk - TriplyDB

Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.

Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.

http://www.wikidata.org/entity/Q47615275

about

Surgical and molecular pathology of pancreatic neoplasms Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer Human β-cell proliferation and intracellular signaling: part 3 Summary of emerging personalized medicine in neuroendocrine tumors: are we on track?Menin determines K-RAS proliferative outputs in endocrine cells Islet biology, the CDKN2A/B locus and type 2 diabetes risk.Inflammatory mechanisms contributing to pancreatic cancer development.Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors.Nuclear receptors and pathogenesis of pancreatic cancer.Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN.DNA promoter hypermethylation of p16 and APC predicts neoplastic progression in Barrett's esophagus O6-Methylguanine-DNA methyltransferase status in neuroendocrine tumours: prognostic relevance and association with response to alkylating agents Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome.Advances in biomarker research for pancreatic cancer.Molecular pathology of pancreatic neuroendocrine tumors.Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.p53 and p16Ink4a/p19Arf Loss Promotes Different Pancreatic Tumor Types from PyMT-Expressing Progenitor Cells Epigenetic changes in gliomas.Deletion of retinoic acid receptor β (RARβ) impairs pancreatic endocrine differentiation.Molecular pathogenesis of pancreatic neuroendocrine tumors.NETs: organ-related epigenetic derangements and potential clinical applications.Epigenetics of gastroenteropancreatic neuroendocrine tumors: A clinicopathologic perspective.Clinical and Preclinical Advances in Gastroenteropancreatic Neuroendocrine Tumor Therapy.The Treatment Landscape and New Opportunities of Molecular Targeted Therapies in Gastroenteropancreatic Neuroendocrine Tumors.

P2860

Q26748615-FB4A6495-B038-4BA0-9825-F968CFBA1F09 Q26785691-B84A28AF-4E9D-4C8A-A660-E36521FC03E1 Q26821954-B0CD6295-687C-4C6D-9DB7-697E6E3937D5 Q28078610-64D94183-C1F6-4E34-921B-D0717811D4B3 Q28589291-28EA5F10-AA64-4EAE-9662-973969751510 Q30251397-7D037D82-4A5E-47A0-9578-88E717C3CF9F Q31067795-91E7D898-1493-435D-894F-32A8310C9A1F Q33991964-56753FAF-D817-409C-9C15-D954E66D5CD2 Q34168476-4E2E4AD5-674D-429A-A415-76E3EE96868D Q34661643-552A160F-A791-441C-BE19-0AD9506776C3 Q34958192-2D716D8C-3D77-42DA-A222-F2F2F20CD1B7 Q35677887-B1DF717B-3BF9-4191-8004-52AB3A129F3F Q35922060-ADA772D1-6CDE-40FE-AEE1-08C0BC8D1052 Q36126609-E5F69F17-5F4F-4BA5-AE0E-054EC4909AB6 Q36162528-5F85F836-731A-406E-B9A3-0991829F8A2A Q37175960-5E5E353E-AA40-4F72-AC7E-3CAF331E420D Q37280291-BE2BFD76-DF62-45EC-863E-97542CED2D7E Q37287032-41F2238B-BFE7-4DE3-A228-880F5982694E Q37290650-E59B2070-0113-4F9F-B538-C08AF0BBB951 Q38166586-61D9AC47-863D-415B-824D-ED2D1A0E7623 Q38841735-7DEC3D21-592E-4FEB-87DC-7D04EEA8C3FD Q42115029-FF70143F-641E-430E-847C-29ED396DF5B0 Q47128709-1AB49D0E-872C-428B-9BBE-1AC2A0D0E4B9 Q48295398-FC2BA45A-7335-47D9-9CCA-84249524E01C

P2860

Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.

http://www.wikidata.org/entity/Q47615275

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.

@en

Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.

@nl

type

label

Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.

@en

Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.

@nl

prefLabel

Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.

@en

Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.

@nl

P1433

Q47615275-15973F28-C5B2-4766-81AA-07F1AA3C31BD

P1476

Q47615275-D25A850B-FFD5-4B84-828E-83EA2BC1BB9F

P2093

Q47615275-0729F2E8-DCA3-4414-B771-A40C8C86D9F6

Q47615275-1312364E-3DD7-4B61-9E6C-C9FCBC1AA4E2

Q47615275-21DFF6AF-ABAD-45B2-8E60-0DA3C1D364CC

Q47615275-5E92F0D9-572B-4E99-B7ED-2D1E8E704364

Q47615275-73C701AB-008F-4F2F-A836-D205C499D470

Q47615275-7ABC44B3-D465-4E7D-AC20-3D9A2C407132

Q47615275-80E8EF7B-F459-4ABE-8AEB-74FCE3EA7C64

Q47615275-AEEE1B87-4FAD-4873-B655-4AA0745E38B9

Q47615275-B8168B48-C8F9-458B-8B3A-B33DFCF60C2F

P2860

Q47615275-046F10C1-CA1F-4773-9F69-C6E480C10B1D

Q47615275-16BB526A-0F12-4F09-B497-9EA543533922

Q47615275-1AC55846-4865-48D2-9118-5D97AA28B713

Q47615275-1EB35A10-1738-4214-9DF1-7B0280CB01DE

Q47615275-25C9C2E0-AC7F-4C23-8910-F8D766A9C9F2

Q47615275-34DA72E6-E026-4C22-8A65-3F0EF3516B15

Q47615275-36CD6F19-B0F8-4060-90E4-63352B90A1B2

Q47615275-3A4EB22A-70E4-420E-BA30-C95899547FB6

Q47615275-4667FEB7-2324-440F-96F6-37739DAB047A

Q47615275-48C44F93-9748-4AB0-A7DB-48BFDA4A95DF

P304

Q47615275-EFFF0865-691A-484A-823E-759A698D21D3

P31

Q47615275-7168D51A-CFF6-4CD8-8D28-50BD5E77C0BF

P356

Q47615275-2CC65B04-8F7E-41B2-9110-0363AACA99FE

P407

Q47615275-52692C4B-A522-4E12-B77F-3393B3AB0716

P433

Q47615275-80380E20-6452-4ADF-A3B6-E183DC4F7249

P478

Q47615275-44CE9E12-C430-4867-B6E8-3F4388CFC5EE

P50

Q47615275-70C71C9A-4158-48A2-807A-9D20F3164A96

P577

Q47615275-984F518C-BD93-462F-8DF7-D0F659909E45

P5875

Q47615275-8BC18C65-1030-4389-9185-B4DD40B1FDE9

P698

Q47615275-1AAB754B-61E6-4CE2-B36D-2427AED17FE4

P932

Q47615275-03470413-2A7F-4136-92C5-1269994A0927

P356

01.SLA.0000086659.49569.9E

P1433

Annals of Surgery

P1476

Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.

@en

P2093

Anirban Maitra

http://www.w3.org/2001/XMLSchema#string

Charles J Yeo

http://www.w3.org/2001/XMLSchema#string

Craig M Hooker

http://www.w3.org/2001/XMLSchema#string

James G Herman

http://www.w3.org/2001/XMLSchema#string

John L Cameron

http://www.w3.org/2001/XMLSchema#string

Keith D Lillemoe

http://www.w3.org/2001/XMLSchema#string

Michael G House

http://www.w3.org/2001/XMLSchema#string

Ming Zhou Guo

http://www.w3.org/2001/XMLSchema#string

Richard D Schulick

http://www.w3.org/2001/XMLSchema#string

P2860

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

A gene hypermethylation profile of human cancer

Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription

Cancer cell cycles

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma

Cancer epigenetics comes of age

Pancreatic neuroendocrine neoplasms: a current summary of diagnostic, prognostic, and differential diagnostic information.

Pancreatic endocrine tumors: recent advances.

Carcinoid and pancreatic endocrine tumors: recent advances in molecular pathogenesis, localization, and treatment.

Molecular pathology of pancreatic cancer.

P304

423-31; discussion 431-2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.SLA.0000086659.49569.9E

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

238

http://www.w3.org/2001/XMLSchema#string

P50

Ralph H. Hruban

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9086583

http://www.w3.org/2001/XMLSchema#string

P698

14501508

http://www.w3.org/2001/XMLSchema#string

P932

1422710

http://www.w3.org/2001/XMLSchema#string